Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypochondroplasia: full-pipeline trial registry
3 of 5 indexed Hypochondroplasia trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Hypochondroplasia: 5 US clinical trials tracked, 3 recruiting.
Hypochondroplasia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is BioMarin Pharmaceutical, running 3 of these trials.
Enrollment posture brief
Registry condition hypochondroplasia
OPEN 3 | RECR 60% | LATE 1 | EARLY 1 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Hypochondroplasia lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypochondroplasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypochondroplasia is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hypochondroplasia research.
BioMarin Pharmaceutical accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most Hypochondroplasia trials plan to enrol fewer than 100 people.
Median target enrolment is 91 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Hypochondroplasia research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
BioMarin Pharmaceutical
NCT06212947
Prospective Clinical Assessment Study in Children With Hypochondroplasia
QED Therapeutics, a BridgeBio company
NCT06410976
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
BioMarin Pharmaceutical
NCT07126262
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
BioMarin Pharmaceutical
NCT06455059
C-Type Natriuretic Peptide and Achondroplasia
Nemours Children's Clinic
NCT01541306
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hypochondroplasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypochondroplasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypochondroplasia page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Hypochondroplasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- BioMarin Pharmaceutical sponsors the most Hypochondroplasia trials on record, review their full trial history before evaluating a specific study. See BioMarin Pharmaceutical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypochondroplasia condition card totals 5 registered trials; most-linked intervention Vosoritide; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.